Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
Go back to Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.48 -1.53 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.01 | 52 Week High | $118.49 | |||
| Open | $125.09 | 52 Week Low | $55.00 | |||
| Day High | $126.31 | P/E | N/A | |||
| Day Low | $123.65 | EPS | $-0.56 | |||
| Volume | 528,746 | |||||
